Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study

Strober Bruce; Bagel Jerry; Lebwohl Mark; Gold Linda Stein; Jackson J. Mark; Chen Rongdean; Goncalves Joana; Levi Eugenia; Duffin Kristina Callis

首页> 外文期刊>Journal of drugs in dermatology: JDD >Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study

【24h】

Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study

机译：中等BSA中度斑块牛皮癣患者的疗效和安全性：第16周推出的研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Introduction: Many options are available for patients with moderate to severe plaque psoriasis. Patients with moderate disease, however, are often undertreated and do not achieve satisfactory clearance. UNVEIL (NCT02425826) assessed efficacy and safety of apremilast in patients with chronic moderate plaque psoriasis.

机译：简介：适度至严重斑块牛皮癣的患者提供了许多选择。然而，患有中度疾病的患者往往是未治疗的，并且不会达到满意的间隙。揭幕（NCT02425826）评估了慢性中等斑块牛皮癣患者的Apremilast的疗效和安全性。

著录项

来源
《Journal of drugs in dermatology: JDD》 |2017年第8期|共8页
作者
Strober Bruce; Bagel Jerry; Lebwohl Mark; Gold Linda Stein; Jackson J. Mark; Chen Rongdean; Goncalves Joana; Levi Eugenia; Duffin Kristina Callis;
展开▼
作者单位

Univ Connecticut Farmington CT 06030 USA;

Psoriasis Treatment Ctr Cent New Jersey East Windsor NJ USA;

Icahn Sch Med Mt Sinai New York NY 10029 USA;

Henry Ford Hlth Syst West Bloomfield MI USA;

Univ Louisville Forefront Dermatol Louisville KY 40292 USA;

Celgene Corp Summit NJ USA;

Celgene Corp Summit NJ USA;

Celgene Corp Summit NJ USA;

Univ Utah Salt Lake City UT USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study [J] . Strober Bruce, Bagel Jerry, Lebwohl Mark, Journal of drugs in dermatology: JDD . 2017,第8期

机译：中等BSA中度斑块牛皮癣患者的疗效和安全性：第16周推出的研究
2. Efficacy and Safety of Apremilast in Systemic- and Biologic-Naive Patients With Moderate Plaque Psoriasis: 52-Week Results of UNVEIL [J] . Gold Linda Stein, Bagel Jerry, Lebwohl Mark, Journal of drugs in dermatology: JDD . 2018,第2期

机译：适量和生物肛门牛皮癣患者对4月份和生物静脉患者的疗效和安全：52周的展开效果
3. Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1) [J] . Papp Kim, Reich Kristian, Leonardi Craig L., Journal of the American Academy of Dermatology . 2015,第1期

机译：口服磷酸二酯酶4（PDE4）抑制剂Apremilast在中度至重度斑块状牛皮癣患者中的应用：一项III期随机对照试验的结果（疗效和安全性试验，评估Apremilast对牛皮癣的影响[ESTEEM] 1）
4. IMANI-1 TC3WP Single Drug HAART -Proof of Concept Study Pilot Study of the Safety and Efficacy of Kaletra (LPV/r) as Single Drug HAART in HIV+ ARV- Naive Patients - Interim Analysis of Subjects Completing Final 48 Week Data [C] . J.C. Gathe Jr., M. Washington, C. Mayberry International AIDS Conference . 2004

机译：Imani-1 TC3WP单药搭载概念研究试验试验研究Kaletra（LPV / R）作为艾滋病毒+ ARV天真患者单药HAART的安全性和有效性 - 临时分析受试者完成最终的48周数据
5. The impact of pruritus on the health-related quality of life of patients with chronic plaque psoriasis [D] . Majeski, Candace Julie Ann 2006

机译：瘙痒对慢性斑块牛皮癣患者健康有关质量的影响
6. The efficacy and safety of apremilast etanercept and placebo in patients with moderate‐to‐severe plaque psoriasis: 52‐week results from a phase IIIb randomized placebo‐controlled trial (LIBERATE) [O] . K. Reich, M. Gooderham, L. Green, -1

机译：apremilast依那西普和安慰剂对中度至重度斑块状牛皮癣的疗效和安全性：IIIb期随机安慰剂对照试验（LIBERATE）的52周结果
7. Efficacy and safety of apremilast in patients with moderate to severe plaque psoriasis of the scalp: results up to 32 weeks from a randomised, phase 3 study [O] . A.S. Van Voorhees, L. Stein Gold, M. Lebwohl, 2021

机译：患有中度至重度斑块牛皮癣患者的疗效和安全性的疗效和安全性：从随机，第3期研究中的结果最多32周

Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study

摘要

著录项

相似文献

相关主题

期刊订阅